Literature DB >> 9162447

How smoking affects blood pressure.

P Omvik1.   

Abstract

The addictive effects of smoking are only partly known, but it is likely that hemodynamic effects of tobacco smoking may contribute to the habituation. It has since long been known that blood pressure and heart rate increase during smoking. These effects are specifically associated with nicotine while the other components of which more than a thousand have been isolated seem to be of minor importance. The rise in blood pressure is due both to an increase in cardiac output and total peripheral vascular resistance. The blood pressure rise appears immediately and occurs before any increase in circulating catecholamines. In hypertensive patients the blood pressure lowering effect of beta-blockers may be partly abolished by tobacco smoking whereas alpha-receptor blockers seem to maintain the antihypertensive efficacy in smokers. It is a paradox that while smoking acutely increases blood pressure, a slightly lower blood pressure level has been found among smokers than nonsmokers in larger epidemiological studies. Because blood pressure may increase after cessation of smoking, a smoke quitting program should not postpone initiation of antihypertensive treatment in patients otherwise in need of such treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162447     DOI: 10.3109/08037059609062111

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  37 in total

1.  Contemporary management of refractory hypertension.

Authors:  A B Alper; D A Calhoun
Journal:  Curr Hypertens Rep       Date:  1999-10       Impact factor: 5.369

2.  Mouse strain-specific acute respiratory effects of nicotine unrelated to nicotine metabolism.

Authors:  A J Bloom
Journal:  Toxicol Mech Methods       Date:  2019-06-21       Impact factor: 2.987

3.  Reproducibility of masked hypertension among adults 30 years or older.

Authors:  Anthony J Viera; Feng-Chang Lin; Laura A Tuttle; Emily Olsson; Kristin Stankevitz; Susan S Girdler; J Larry Klein; Alan L Hinderliter
Journal:  Blood Press Monit       Date:  2014-08       Impact factor: 1.444

4.  Arterial Compliance and Autonomic Functions in Adult Male Smokers.

Authors:  Sukhmani Saini; Yogesh Saxena; Rani Gupta
Journal:  J Clin Diagn Res       Date:  2016-05-01

5.  Smoking patterns and chronic kidney disease in US Hispanics: Hispanic Community Health Study/Study of Latinos.

Authors:  Nora Franceschini; Yu Deng; Michael F Flessner; John H Eckfeldt; Holly J Kramer; James P Lash; David J Lee; Michal L Melamed; Ashley E Moncrieft; Ana C Ricardo; Sylvia E Rosas; Robert C Kaplan; Leopoldo Raij; Jianwen Cai
Journal:  Nephrol Dial Transplant       Date:  2016-06-02       Impact factor: 5.992

Review 6.  Nonpharmacologic therapy for hypertension: does it really work?

Authors:  Thor Tejada; Alessia Fornoni; Oliver Lenz; Barry J Materson
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

Review 7.  Management of the hypertensive patient who smokes.

Authors:  H Pardell; R Tresserras; E Saltó; P Armario; R Hernández
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

8.  Asthma, environmental risk factors, and hypertension among Arab Americans in metro Detroit.

Authors:  Markey Johnson; Jerome Nriagu; Adnan Hammad; Kathryn Savoie; Hikmet Jamil
Journal:  J Immigr Minor Health       Date:  2008-11-08

9.  Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

Authors:  Tanya N Turan; Jenifer H Voeks; Marc I Chimowitz; Ana Roldan; Todd LeMatty; William Haley; Maria Lopes-Virella; Seemant Chaturvedi; Michael Jones; Donald Heck; George Howard; Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Stroke       Date:  2020-09-21       Impact factor: 7.914

10.  Sociodemographic correlates of four indices of blood pressure and hypertension among older persons in Japan.

Authors:  Shieva Davarian; Eileen Crimmins; Atsuhiko Takahashi; Yasuhiko Saito
Journal:  Gerontology       Date:  2013-05-15       Impact factor: 5.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.